Abstract
Alzheimer's Disease (AD) is one of the leading causes of dementia in the elderly, characterized by progressive cognitive decline. Individuals with Mild Cognitive Impairment (MCI) can follow two distinct outcomes: remaining stable (sMCI) or progressing to AD (pMCI). Early prediction of this progression is crucial for more effective therapeutic interventions, enabling disease progression de…